背景:乳房缩小手术是一种广泛进行的整形外科手术。近年来,此类并发症的发生率一直在稳步下降,但仍为5.6%。本研究的主要目的是分析乳房缩小手术的主要术后并发症的发生率。此外,我们确定了并发症和患者特征之间的因果关系,比如吸烟,年龄,重量切除,BMI,和伤口引流。
方法:这项回顾性研究是对2016年1月至2022年10月在圣路易斯医院整形外科病房接受乳房缩小手术的1442名妇女进行的。巴黎,法国。在后续检查中,我们评估了患者的并发症.
结果:在平均BMI为28.9的人群中,平均切除重量为1297.7g。我们发现总并发症的发生率为19.9%,其中3.5%为主要并发症。我们发现,只有切除重量是并发症的危险因素。
结论:我们研究的主要优势在于样本的大小。尽管某些事件很少,但大量患者使我们能够进行大量分析并获得重要结果。这个庞大的队列也是我们结果的高统计能力的原因。
结论:小于2.4kg的切除术后发生感染的风险为7.5%,高于该比例时增加到13.9%。因此,对受影响的妇女进行预防性抗生素治疗以降低感染风险是一个独特的考虑因素.对于其他因素,虽然它们都没有出现促进不良事件的发生,因此,不要正式禁止乳房缩小手术,我们仍然认为一些预防措施是相关的,如叶片排水,减肥,糖尿病控制,和戒烟。
方法:本期刊要求作者为每篇文章分配一定程度的证据。对于这些循证医学评级的完整描述,请参阅目录或在线作者说明www。springer.com/00266.
BACKGROUND: Breast reduction surgery is a widely performed plastic surgery procedure. The incidence of such complications has been steadily decreasing in recent years but is still nonetheless 5.6%. The primary aim of this study was to analyze the incidence of the main postoperative complications of breast reduction surgery. In addition, we identified cause-and-effect links between complications and characteristics of the patients, such as smoking, age, weight resection, BMI, and wound drainage.
METHODS: This retrospective study was performed on a population of 1442 women who underwent breast reduction surgery between January 2016 and October 2022 in the plastic surgery unit at Saint-Louis Hospital, Paris, France. At the follow-up examination, we evaluated the patients for complications.
RESULTS: The average resection weight was 1297.7 g in a population for which the average BMI was 28.9. We found 19.9% rate of total complications, of which 3.5% were major complications. We found that only the resection weight was a risk factor for complications.
CONCLUSIONS: The main strength of our study is the size of our sample. The large number of patients allowed us to conduct numerous analyses and obtain significant results despite the rarity of certain events. This large cohort was also responsible for the high statistical power of our results.
CONCLUSIONS: The risk of developing a postoperative infection was 7.5% for resections of less than 2.4 kg, increasing to 13.9 % when greater than that. Thus, the administration of prophylactic antibiotic therapy to affected women to reduce the risk of infection is a distinct consideration. For the other factors, while none of them appeared to promote the occurrence of adverse events and, therefore, do not formally contraindicate breast reduction surgery, some preventive measures still strike us as being relevant, such as blade drainage, weight loss, diabetes control, and smoking cessation.
METHODS: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .